Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.4ef856b8.1765492044.9e72d26
Business
Read More
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.a7f5d217.1765488355.cad84048
Thomas O. Hicks, Texas Money Man Who Owned 3 Teams, Dies at 79
A master of leveraged buyouts, he bought baseball and hockey teams in Texas and an English soccer club, only to lose them in an avalanche of debt.
The Hollywood Studio Tour Has Become a Lot of Nothing
It’s hard to make a movie studio tour exciting when movies aren’t made there anymore. “A vibe of tiredness, like the end of something,” one guest said.
Eli Lilly’s weight loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered what appears to be the highest weight loss yet in a late-stage trial while reducing knee arthritis pain, clearing the first of several upcoming…
Unlocking Productive Conflict on Your Executive Team
An HBR Executive Masterclass with Amy Gallo. by HBR Editors December 10, 2025 Most executive teams believe that harmony equals health. Meetings run smoothly. People nod along. No one pushes back. But according to Amy Gallo, author of HBR Guide to Dealing with Conflict and a renowned expert on the topic, that’s not a sign…
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.a7f5d217.1765459034.c5774b48
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.3d72c117.1765455328.6ec7c0d
Fed Divisions Underscore Challenge for Trump’s Next Chair
President Trump wants substantially lower borrowing costs, but officials at the central bank appear ready to resist delivering further cuts if the economic backdrop does not warrant it.
USA Today’s Top Editor Departs, the Second in Less Than Two Years
Caren Bohan, who was named editor in chief in September 2024, will no longer continue in her role “effective immediately,” the company told employees.